Data presented are from a sex-differences secondary analysis of a human laboratory investigation of single doses of atomoxetine (40 mg and 80 mg) versus placebo in abstinent individuals with cocaine use disorders (CUD). Subjective drug effects, cognitive performance and cardiovascular measures were assessed. The primary atomoxetine dose analyses (which do not consider sex as a factor) are reported in full elsewhere (DeVito et al., 2017) [1].
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5568877 | PMC |
| http://dx.doi.org/10.1016/j.dib.2017.08.011 | DOI Listing |
Publication Analysis
Top Keywords
atomoxetine abstinent
4
abstinent cocaine
4
cocaine users
4
users sex
4
sex differences
4
differences data
4
data presented
4
presented sex-differences
4
sex-differences secondary
4
secondary analysis
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!